Oleunor N7e (Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac)

Oleunor N7e is a multi‑mineral formulation that acts on electrolyte homeostasis and metabolic pathways.

• Electrolyte imbalance correction: Helps restore normal sodium, potassium, calcium and magnesium levels in patients with documented deficiencies.
• Peri‑operative support: Provides essential minerals that support neuromuscular function during surgical procedures.
• Critical‑care nutrition: Contributes to overall electrolyte balance in intensive care settings.

• Oleunor N7e supplies a blend of glycine, magnesium chloride, potassium chloride, calcium chloride and L‑lysine, which act as cofactors and electrolytes in cellular metabolism. The minerals participate in enzymatic reactions, nerve impulse transmission, and muscle contraction, while glycine functions as a neurotransmitter and osmolyte, collectively supporting physiological homeostasis.

Adverse reactions reported with multi‑mineral intravenous preparations are generally related to the individual components and the infusion process.

Common Side Effects

• Mild nausea or vomiting
• Transient flushing or warmth at the infusion site
• Headache
• Mild hypotension
• Localized irritation or erythema
• Slight increase in serum magnesium levels

Serious or Rare Side Effects

• Severe hyper‑kalemia or hyper‑magnesemia
• Anaphylactic or severe allergic reaction
• Cardiac arrhythmia due to electrolyte shifts
• Acute calcium overload causing vascular calcification
• Renal impairment from rapid electrolyte load
• Pulmonary edema from fluid overload

When using Oleunor N7e, clinicians should assess patient-specific factors and monitor relevant parameters.

• Renal function: Evaluate baseline kidney function and adjust infusion rates accordingly.
• Cardiac status: Monitor ECG and serum electrolytes in patients with known heart disease.
• Fluid balance: Track input‑output to avoid volume overload.
• Concomitant electrolytes: Review other mineral supplements to prevent cumulative excess.
• Pregnancy and lactation: Use only if clearly indicated and benefits outweigh risks.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Oleunor N7e may interact with other medications that influence electrolyte balance or renal excretion.

Major Interactions (Avoid)

• Loop diuretics: May exacerbate electrolyte depletion if not carefully balanced.
• ACE inhibitors or ARBs: Can increase serum potassium, raising hyper‑kalemia risk.
• Calcium channel blockers: Potential additive effects on calcium levels.

Moderate Interactions (Monitor Closely)

• Antacids containing magnesium or aluminum: May contribute to excess magnesium.
• Certain antibiotics (e.g., aminoglycosides): Electrolyte shifts can affect drug toxicity.
• Insulin therapy: Rapid shifts in potassium may alter glucose control.